Piper Sandler has recently initiated Karyopharm Therapeutics Inc (KPTI) stock to Overweight rating, as announced on January 19, 2023, according to Finviz. Earlier, on November 4, 2022, RBC Capital ...
Some results have been hidden because they may be inaccessible to you